These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23763979)

  • 21. Six cases of antihistamine-resistant dermographic urticaria treated with oral ciclosporin.
    Toda S; Takahagi S; Mihara S; Hide M
    Allergol Int; 2011 Dec; 60(4):547-50. PubMed ID: 21778816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased D-dimer concentration in plasma of patients with severe acute urticaria.
    Kasperska-Zajac A; Brzoza Z
    Br J Dermatol; 2009 Dec; 161(6):1409-10. PubMed ID: 19754863
    [No Abstract]   [Full Text] [Related]  

  • 23. Omalizumab is effective in nonautoimmune urticaria.
    Ferrer M; Gamboa P; Sanz ML; Goikoetxea MJ; Cabrera-Freitag P; Javaloyes G; Berroa F; Kaplan AP
    J Allergy Clin Immunol; 2011 May; 127(5):1300-2. PubMed ID: 21315432
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of chronic urticaria in children with antihistamines and cyclosporine.
    Neverman L; Weinberger M
    J Allergy Clin Immunol Pract; 2014; 2(4):434-8. PubMed ID: 25017532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe chronic urticaria is associated with elevated plasma levels of D-dimer.
    Asero R; Tedeschi A; Riboldi P; Griffini S; Bonanni E; Cugno M
    Allergy; 2008 Feb; 63(2):176-80. PubMed ID: 17961199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine.
    Hiragun M; Hiragun T; Mihara S; Akita T; Tanaka J; Hide M
    Allergy; 2013 Feb; 68(2):229-35. PubMed ID: 23205732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab.
    Magerl M; Staubach P; Altrichter S; Ardelean E; Krause K; Metz M; Weller K; Maurer M
    J Allergy Clin Immunol; 2010 Sep; 126(3):665-6. PubMed ID: 20673981
    [No Abstract]   [Full Text] [Related]  

  • 28. An update on acute and chronic urticaria for the primary care provider.
    Najib U; Sheikh J
    Postgrad Med; 2009 Jan; 121(1):141-51. PubMed ID: 19179823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial.
    Maurer M; Schütz A; Weller K; Schoepke N; Peveling-Oberhag A; Staubach P; Müller S; Jakob T; Metz M
    J Allergy Clin Immunol; 2017 Sep; 140(3):870-873.e5. PubMed ID: 28389391
    [No Abstract]   [Full Text] [Related]  

  • 30. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
    Nelson HS; Reynolds R; Mason J
    Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Self assessment of the effect of antihistaminics by patients with chronic recurring urticaria].
    Ziegler B; Haustein UF
    Dermatol Monatsschr; 1986; 172(3):163-7. PubMed ID: 3699212
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma D-dimer levels and clinical response to ciclosporin in severe chronic spontaneous urticaria.
    Asero R
    J Allergy Clin Immunol; 2015 May; 135(5):1401-3. PubMed ID: 25542882
    [No Abstract]   [Full Text] [Related]  

  • 33. Activation of coagulation in chronic urticaria in relation to disease severity and activity.
    Farres MN; Refaat M; Melek NA; Ahmed EE; Shamseldine MG; Arafa NA
    Allergol Immunopathol (Madr); 2015; 43(2):162-7. PubMed ID: 25088671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of omalizumab to antihistamine treatment in chronic urticaria: A real-world study in China.
    Chen YD; Maurer M; Yu M; Tu P; Zhao ZT
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):217-219. PubMed ID: 32371240
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of Refractory Chronic Spontaneous Urticaria with Adalimumab.
    Bangsgaard N; Skov L; Zachariae C
    Acta Derm Venereol; 2017 Apr; 97(4):524-525. PubMed ID: 27840884
    [No Abstract]   [Full Text] [Related]  

  • 36. "Chronic Urticaria": Recommendations From an Allergist and Immunologist.
    Awosika O; Qureshi A; Ehrlich A; Fonacier L
    Dermatitis; 2018; 29(5):292-293. PubMed ID: 30179970
    [No Abstract]   [Full Text] [Related]  

  • 37. Rupatadine in allergic rhinitis and chronic urticaria.
    Mullol J; Bousquet J; Bachert C; Canonica WG; Gimenez-Arnau A; Kowalski ML; Martí-Guadaño E; Maurer M; Picado C; Scadding G; Van Cauwenberge P
    Allergy; 2008 Apr; 63 Suppl 87():5-28. PubMed ID: 18339040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost, utilization, and patterns of medication use associated with chronic idiopathic urticaria.
    Zazzali JL; Broder MS; Chang E; Chiu MW; Hogan DJ
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):98-102. PubMed ID: 22289728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
    Maurer M; Altrichter S; Bieber T; Biedermann T; Bräutigam M; Seyfried S; Brehler R; Grabbe J; Hunzelmann N; Jakob T; Jung A; Kleine-Tebbe J; Mempel M; Meurer M; Reich K; Ruëff F; Schäkel K; Sengupta K; Sieder C; Simon JC; Wedi B; Zuberbier T; Mahler V; Staubach P
    J Allergy Clin Immunol; 2011 Jul; 128(1):202-209.e5. PubMed ID: 21636116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omalizumab also successful in chronic urticaria.
    Spector SL; Tan RA
    J Allergy Clin Immunol; 2008 Mar; 121(3):784; author reply 784-5. PubMed ID: 18328900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.